# ğŸ“œ Workstream Updates {transition="slide-in none"}

## ğŸ— Key Policy Updates!

- R Submissions Working group Pioneering use of Containers for delivering
  study analysis with positive health authority feedback.[^pharmasug]

### Reminder: News within the last year
  
- The FDA appears to accept `.R` files through their eSUB portal[^esub].
- The FDA has released a draft of a new _Computer Software Assurance[^csa]_ guideline
  that seems to be increasingly the basis for their evaluation of R.

[^pharmasug]: [PharmaSUG 2024 #SS-376](https://www.pharmasug.org/us/2024/papers.html#SS-376)
[^esub]: [R Consortium R Submission WG, Pilot #1](https://github.com/RConsortium/submissions-pilot1)
[^csa]: [_Computer Software Assurance for Production and Quality Systems Software: Draft Guidance for Industry and Food and Drug Administration Staff_](https://www.fda.gov/media/161521/download)

# ğŸ“£ Communications Workstream

- ğŸ“ Community Meetings
- ğŸš§ Website Revamp
- ğŸ“œ Case Studies Refresh
- ğŸ†• Gathering GxP Package Lists

## ğŸ“ Community Meetings

### Past meetups ğŸ“†

- Jun 27, 2023 - *Learnings & Reflections from Case Studies* 
- Aug 09, 2023 - *{riskmetric} & the {riskassessment} app â€“ A 2-part Mini Series* 
- Nov 28, 2023 - *Wrapping Up 2023 and Welcoming 2024* 
- Feb 03, 2024 - *Unraveling the Term â€œValidationâ€* 
- May 21, 2024 - *Tackling Hurdles: Embracing Open-Source Packages in Projects* 

<br>

### How do I sign up?
- âœ‰ Join our [mailing list](https://lists.r-consortium.org/g/RConsortium-Validation-Hub)!
- Follow the [R Consortium's Linkedin](https://www.linkedin.com/company/r-consortium/posts/)


## ğŸ“ Next Community Meeting


:::: {.columns}

::: {.column width="30%"}
![](resources/brid_roberts.jpg){height="7.4em" style="margin-left:50px;"}
:::
::: {.column width="45%"}

<br>

ğŸ—“ï¸ Tues, Aug 20, 2024

ğŸ‘©â€ğŸ¦° BrÃ­d Roberts

âŒ¨ï¸ Novartis

:::
::::

### Analyzing change in assessed risk across package releases 

> The Software Open Source (SOS) team manages and executes the risk assessment process for R package validation at Novartis. The team uses an internally developed R package to classify the risk of each package as "low", "medium", or "high".
> 
> We analysed the risk assessment data over two time points to determine the impact on the assigned risk categorisation for packages with AND without version changes. 
> 
> In this talk, we showcase the risk assessments over time, the causes of any risk class changes, and  their impact on various teams within our organizations as a result.

# ğŸš§ Website Refresh
[pharmaR.org](https://www.pharmar.org/)


## `pharmaR.org` THEN

![](resources/website-old.png)


## `pharmaR.org` NOW

![](resources/website-new.png){style="border-color:black; border-style:solid; border-width:5px;"}


## ğŸ“œ Case Studies Refresh

![](resources/website-case-studies.png){style="border-color:black; border-style:solid; border-width:5px;"}


## ğŸ†• Gathering GxP Package Lists



# ![](resources/riskassessment.png){height="1.8em" width="1.8em" style="margin: 0 0.2em; object-fit: contain;vertical-align: middle;"} `{riskassessment}` App

- â° Latest features 
- ğŸ†• New Collaborative Deployment
- ğŸ›£ï¸ Where we're headed next




## ![](resources/riskassessment.png){height="1.8em" width="1.8em" style="margin: 0 0.2em; object-fit: contain;vertical-align: middle;"} `{riskassessment}` App

### Latest Features Recap

* Expanded decision automation to include individual {riskmetric} assessment values
* New `Function Explorer` page and faster exploration of source code
* Expanded the package dependency view
* Miscellaneous items
  
### ğŸ“£ The feedback loop is crucial!
All of these improvements started off as community-driven suggestions on our GitHub repo. If you have an idea that doesn't already exist on the [existing list](https://github.com/pharmaR/riskassessment/issues) of issues, [submit a new issue](https://github.com/pharmaR/riskassessment/issues/new) today and it may become a reality tomorrow.
  
  
  
  
## ![](resources/riskassessment.png){height="1.8em" width="1.8em" style="margin: 0 0.2em; object-fit: contain;vertical-align: middle;"} `{riskassessment}` App

### ğŸ†• New Collaborative Deployment

[https://app.pharmar.org/riskassessment/](https://app.pharmar.org/riskassessment/)

Call for volunteer "Leads"
Big thanks to ProCogia TODO: insert logo




## ![](resources/riskassessment.png){height="1.8em" width="1.8em" style="margin: 0 0.2em; object-fit: contain;vertical-align: middle;"} `{riskassessment}` App Enhancement

### Decision Automation Rules, by metric assessment

## ![](resources/riskassessment.png){height="1.8em" width="1.8em" style="margin: 0 0.2em; object-fit: contain;vertical-align: middle;"} `{riskassessment}` App Enhancement

### New Function Explorer! (Code provided by _GSK_)


## ![](resources/riskassessment.png){height="1.8em" width="1.8em" style="margin: 0 0.2em; object-fit: contain;vertical-align: middle;"} `{riskassessment}` App Enhancement

### Package Dependency Integration


## ![](resources/riskassessment.png){height="1.8em" width="1.8em" style="margin: 0 0.2em; object-fit: contain;vertical-align: middle;"} `{riskassessment}` Roadmap

### ğŸ’¯ Optional: going scoreless

todo: provide details from that open issue




# ![](resources/riskmetric.png){height="1.8em" width="1.8em" style="margin: 0 0.2em; object-fit: contain;vertical-align: middle;"} `{riskmetric}`
- Recap last year's priorities
- ğŸ¥… New Roadmap

## ![](resources/riskmetric.png){height="1.8em" width="1.8em" style="margin: 0 0.2em; object-fit: contain;vertical-align: middle;"} `{riskmetric}` Recap

::: { style="font-size:0.8em" }
- **Ease of use:**  
  Wrapper functions for a a complete workflow, prettier outputs
- **Metric completeness:**  
  Implement metrics for as many pacakge sources as possible. Chain sources 
  together to create more complete assessments
- **Modular additions:**  
  Allow users to easy add custom assessments, create optional assessments 
  based on community packages (e.g. `oyster`, `srr`, `pkgstats`, etc)
- **Focusing on metrics and scoring:**  
  Making custom weighting more robust and convenient. Guidance materials on 
  weighting specific assessments based on community feedback and our own views 
  on best practices.
:::

## ![](resources/riskmetric.png){height="1.8em" width="1.8em" style="margin: 0 0.2em; object-fit: contain;vertical-align: middle;"} `{riskmetric}` Roadmap

![](resources/riskmetric-gov-1.png){height="18em" style="margin-left:50px"}

## ![](resources/riskmetric.png){height="1.8em" width="1.8em" style="margin: 0 0.2em; object-fit: contain;vertical-align: middle;"} `{riskmetric}` Roadmap

![](resources/riskmetric-gov-2.png){height="18em"}

## ![](resources/riskmetric.png){height="1.8em" width="1.8em" style="margin: 0 0.2em; object-fit: contain;vertical-align: middle;"} `{riskmetric}` Roadmap

![](resources/riskmetric-gov-3.png){height="18em"}


